|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Provision for inventory impairment | ||
| Depreciation | ||
| Amortization of right-of-use assets | ||
| Share-based compensation | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | ||
| Prepayments, other receivables and other assets | ||
| Inventories, net | ||
| Right-of-use assets | ||
| Deferred taxes | ||
| Accounts payable | ||
| Other payables and accrued liabilities | ||
| Taxes payable | ||
| Lease liabilities – current | ||
| Lease liabilities – non current | ||
| Net Cash Provided by (Used in) Operating Activities | ||
| Cash Flows from Investing Activities: | ||
| Purchases of property, plant and equipment | ||
| Net Cash (Used in) Investing Activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from IPO | ||
| Payments for deferred offering costs | ||
| Net Cash Provided by (Used in) Financing Activities | ||
| Effect of Exchange Rate Changes on Cash and Equivalents | ||
| Net Increase (Decrease) in Cash and Equivalents | ||
| Cash and Equivalents, – Beginning of Year | ||
| Cash and Equivalents – End of Year |
Loading...
